The Switzerland-based company will use Rockwell’s PharmaSuite Manufacturing Execution System (MES) software to complete its digitization.
John Genovesi, SVP of enterprise accounts and software at Rockwell Automation, said in a statement: “Digital transformation is bringing new levels of operational efficiency, quality, process automation, and employee productivity to pharmaceutical companies globally.”
Rockwell’s solution, according to the company, was designed to avoid disruptions during high volume periods or ‘just-in-time’ orders for on-demand production.
A Lonza spokesperson told us that this project is in line with its “Go Digital” initiative, which will enable electronic batch recording and real-time visibility during processes on the floor at all its manufacturing sites.
Based in Wisconsin, Rockwell will also provide Lonza with access to its FactoryTalk InnovationSuite to enable the biotech to trace products through production down to the individual capsule carton.